|
HS Code |
449018 |
| Cas Number | 37585-83-4 |
| Molecular Formula | C8H8BrCl |
| Molecular Weight | 219.51 g/mol |
| Iupac Name | 5-bromo-2-chloro-1,3-dimethylbenzene |
| Appearance | Colorless to pale yellow liquid |
| Melting Point | -6°C |
| Boiling Point | 230-233°C |
| Density | 1.43 g/cm³ |
| Purity | Typically ≥98% |
| Refractive Index | 1.573 |
| Solubility In Water | Insoluble |
| Flash Point | 104°C |
| Smiles | CC1=CC(=CC(=C1Cl)C)Br |
| Synonyms | 5-Bromo-2-chloro-m-xylene |
| Hazard Statements | May cause respiratory irritation |
As an accredited 5-Bromo-2-Chloro-1,3-Dimethylbenzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2-Chloro-1,3-Dimethylbenzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemical research leans on reliable, well-characterized building blocks. In labs focused on pharmaceuticals, agrochemicals, and advanced materials, 5-Bromo-2-Chloro-1,3-Dimethylbenzene stands out as a trusted workhorse. The compound, with its distinct halogen substitutions and methyl groups on the aromatic ring, brings a subtle but crucial influence to the synthesis of complex molecules. Over years spent in applied organic synthesis, one can’t help but notice how a thoughtful tweak in structure—like swapping or selecting a halogen or a methyl group—drives outcomes in yield, selectivity, or even patentability.
Anyone familiar with organic synthesis probably knows this molecule by its CAS number 118719-37-6 or its systematic name. The structure features a benzene ring that carries both bromo and chloro substitutions, plus two methyl groups set at the 1 and 3 positions on the ring. It presents itself as a white to off-white crystalline powder in most reputable catalogs, with a purity that experienced chemists can trust for downstream reactions—usually not less than 98%. This isn’t just a box to check. Impurities throw off coupling reactions and slow down development projects, leading to weeks or months of troubleshooting that a good starting material can sidestep.
Melting points typically fall between 50 and 55°C. Anyone considering its solubility profile will find it handles well in organic solvents common to laboratory and industrial processes like dichloromethane, chloroform, and toluene. On the shelf, in a sealed container, it proves stable, not prone to caking or rapid degradation in reasonable storage conditions.
The real value in a specialty intermediate like this comes from what it can unlock. To someone sketching out synthetic routes, the combination of a bromine and a chlorine atom in predictable positions offers a springboard for functional group transformations. Cross-coupling reactions define modern organic synthesis, and as someone who has spent years experimenting with palladium and nickel catalysis, there’s a direct appreciation for how a reliable aryl bromide-chloride lets you explore new ligands and reagents without fighting capricious side reactions.
Most often, this compound enables Suzuki, Heck, and Sonogashira couplings. Whether building a molecular scaffold for a new drug candidate or a performance polymer, the selective reactivity of bromine vs. chlorine lets researchers choose which site to modify. The methyl groups, while sometimes considered “silent” by less seasoned chemists, have a concrete impact—adding lipophilicity, influencing metabolic stability, or guiding a molecule into the right conformation for further elaboration.
Development teams chasing new active pharmaceutical ingredients see the value in a molecular fragment like this not only for its ability to participate in well-understood reactions but also because it supports strategic late-stage diversification. In early medicinal chemistry projects, those methyl groups become handles for structure-activity relationship studies. They determine, often subtly, whether an idea moves forward or gets shelved.
Some newcomers to synthesis might wonder why you wouldn’t just work with a simpler aryl halide–something like plain bromotoluene or even chlorotoluene. The problem is that those materials often don’t give the precise selectivity or unique reactivity profile needed when refining lead compounds or specialized intermediates. The dichotomy between bromine and chlorine on the same ring, in this specific arrangement, unlocks orthogonal reactivity not seen in straightforward mono-halogenated benzenes.
It’s tempting to think that a commercially available building block is just a question of availability and price. That approach can cost time and resources. More experienced hands know that switching from a generic p-bromotoluene to a multi-substituted system like 5-Bromo-2-Chloro-1,3-Dimethylbenzene often means fewer steps and more control. In projects racing the clock—for academic grants or industrial deadlines—having an intermediate that introduces two halogen handles and methylation in a single leap can be the key to delivering results before a competitor.
Cost-effectiveness in materials, especially at scale, isn’t just about sticker price. Yields, downstream purification steps, and consistency between batches all matter. In my time overseeing kilo-lab operations, we saw firsthand how differences in starting material quality added up to hundreds of thousands of dollars in wasted solvent, human hours, and lost opportunity. A batch that comes in out of specification slows or halts entire production lines. Selecting the right starting intermediate, validated from a trustworthy supplier, curbs that risk most.
Entering chemical synthesis is often a balancing act. Teams weigh risks against potential. One project in a past role depended on constructing a substituted aromatic core. The options were to take a lengthier synthesis route using less functionalized precursors or to start with a complex halogenated intermediate. The latter—using a product like 5-Bromo-2-Chloro-1,3-Dimethylbenzene—meant fewer steps, lower cumulative hazard exposure, and a clearer path through process development.
Streamlining steps means fewer opportunities for loss, decomposition, or regulatory headache. Safety teams and process engineers often praise a well-chosen intermediate for helping limit exposure to chlorinating or brominating reagents onsite. For global companies, reducing hazardous waste and volatile organic compound emissions doesn’t just check a compliance box. That kind of choice gets reported directly to stakeholders looking for tangible improvements in environmental responsibility.
Decades of collective experience in research labs underscore the same lesson: quality matters. Commercial intermediates that arrive with reproducible purity and consistent lot-to-lot performance support fast troubleshooting and predictable workups. Analytical chemists especially appreciate a clean NMR, straightforward HPLC, and absence of persistent trace contaminants. For active research, nothing breaks momentum faster than an unexpected signal or intractable baseline artifact that leads to confusion or wasted effort.
Making the transition from bench-scale investigation to larger-scale production often brings surprises. Differences in raw material behavior, overlooked moisture content, or variable particle size all become more pronounced. I recall a project where switching to a reliably sourced, high-purity 5-Bromo-2-Chloro-1,3-Dimethylbenzene cut recrystallization time in half and eliminated stubborn carryover that previously reduced the shelf-life of our target molecule.
Every project—whether conducted in a resource-constrained academic lab or a high-throughput industrial pipeline—wrestles with tradeoffs. Spend more on the premium intermediate or invest in extended purification in-house? Hold off in the hope a supplier drops price, or commit now and ensure continuity? The most successful teams I’ve worked alongside focus on how starting material choices ripple through the entire pipeline—from batch-to-batch reproducibility right up to regulatory filing.
Some chemists gravitate to the apparent flexibility of starting simple and building up. The hard-won lesson is that each added step ratchets up risk. An intermediate with multi-functional handles—like 5-Bromo-2-Chloro-1,3-Dimethylbenzene—serves as a shortcut. The efficiency gained here multiplies time and again as the molecule progresses through downstream chemistry. This is even more pronounced in sensitive reactions where selectivity can’t be compromised.
Discovery chemistry thrives on versatility and durability in core building blocks. Complex aromatic intermediates, especially those with precise substitution patterns, drive rapid innovation in product development. Over the years, I’ve seen how a reliable stock of key intermediates lets chemists pivot, experiment, and push boundaries—without halting projects to reoptimize every synthesis.
In the pharmaceutical industry, regulatory pressure now emphasizes traceability, detailed impurity profiling, and source transparency. A clear, well-documented supply chain for 5-Bromo-2-Chloro-1,3-Dimethylbenzene removes ambiguity during audits and accelerates the movement from preclinical stages through regulatory submission. CROs, CDMOs, and internal discovery teams all benefit when intermediates feature robust quality controls and transparent specification data.
Beyond the pharmaceutical world, specialties like crop science, performance polymers, and fine chemical additives draw from the same toolbox. Teams in agricultural chemistry appreciate intermediates that let them rapidly prototype new fungicides or herbicides, dropping or swapping halogen atoms for fine-tuned activity. That flexibility, supported by the reliable performance of a compound like this, means innovations can move from hypothesis to test strip faster than ever.
Selection of a specialty compound is rarely a simple procurement decision. From the chemist’s view, the ripple effects go from labor savings in the hood to less wasted solvent, to faster project timelines, straight through to commercial launch. One of the persistent lessons for teams managing both research and manufacturing has been the importance of communication—integration between chemists, procurement officers, safety engineers, and regulatory staff never happens by accident.
Ensuring robust communication doesn’t just keep projects running. It also exposes pitfalls in what looks, at first glance, like an easy material selection. I’ve witnessed projects grind to a halt over overlooked analytical data—something as straightforward as unexpected chloride content or out-of-range melting points derailing a batch, costing days or weeks. Integrated teams that review both technical datasheets and real-world production outcomes have consistently found value in intermediates whose specifications hold up under scrutiny.
For those in procurement, building relationships with suppliers willing to provide both analytical support and detailed traceability pays off. In many cases, direct discussions with supplier technical teams uncovered specification details that standard catalogs missed. That transparency becomes essential during process changes, API registration, or scaling from kilogram to multi-ton batches. Rapid response and openness regarding source, lot history, and shipping conditions eliminate guesswork and lower long-term quality risks.
Trained eyes recognize patterns in chemical project delays. Typically, sourcing intermediates like 5-Bromo-2-Chloro-1,3-Dimethylbenzene from a narrow roster of vendors breeds risk. A more resilient supply chain comes from qualifying multiple suppliers and building redundancy into procurement. This isn’t just a theoretical benefit—teams that mapped out backup sources cut lead times during global supply hiccups and shielded mission-critical projects from interruption.
Another challenge comes from shifting regulatory requirements. This is especially true in global pharmaceutical R&D hubs, where changing rules around trace impurities, solvent residues, or heavy metals can surprise even seasoned chemists. Exhibiting a forward-thinking approach means requesting and documenting analytical data upfront and pressing suppliers for ongoing compliance updates over the course of multi-year projects. Adjustments midstream become less disruptive when teams lay this groundwork early.
On the technical side, new purification methods and in-process controls help mitigate the downsides of impurities that sometimes sneak into even high-grade intermediates. Automated chromatography, real-time process analytics, and improved solvent systems trim process loss and improve both yield and purity. In-house teams, especially those focused on scale-up, benefit from partnerships with suppliers who support custom purification or batch testing before delivery.
Looking back, moving projects forward always came down to experience. Seasoned teams no longer treat intermediate selection as an afterthought. Listening to analytical chemists, process engineers, and quality inspectors has repeatedly driven better project results. Sourcing a compound like 5-Bromo-2-Chloro-1,3-Dimethylbenzene from transparent, responsive suppliers—with demonstrated expertise in small-molecule chemistry—gives both peace of mind and real competitive advantage.
A proven approach aligns technical capability with strategic relationship management. Teams take time to audit suppliers, request in-depth specification data, and forge collaborations that go beyond the surface. These investments, while sometimes painful upfront, guard against future surprises—whether in bench chemistry, plant scale-up, or final regulatory inspection. Time after time, the value added by a consistent intermediate eclipses marginal price differences on a spreadsheet.
Trends point toward even tighter specifications and more demanding impurity profiles. Innovations in green chemistry and sustainable manufacturing increasingly hinge on intermediates that hit multiple benchmarks at once: low environmental impact, robust performance across multiple reactions, and keen support from suppliers. For 5-Bromo-2-Chloro-1,3-Dimethylbenzene, these industry changes mean that both buyers and producers sharpen their focus on traceability, batch consistency, and environmental impact.
Efforts continue to find new synthetic routes that cut waste, lower emissions, or broaden applicability without sacrificing yield or purity. Automation, advanced analytic tools, and machine learning in reaction scouting open possibilities for even more customized intermediate options ahead. It’s the daily work of researchers and process chemists—inspecting, testing, and refining—that turns these big-picture goals into reality.
Choosing a specialty intermediate like 5-Bromo-2-Chloro-1,3-Dimethylbenzene is far more than a technical checkmark. It draws on experience, judgment, and collaborative insight spanning multiple disciplines. Each batch pulled from the shelf stands as a quiet testament to years of learning about what works—and what doesn’t—across applied and industrial chemistry. For teams looking to push boundaries in pharmaceuticals, crop science, or advanced materials, smart material selection makes all the difference in delivering breakthrough science efficiently, reliably, and safely.